Rejuvorate

About Rejuvorate

At Rejuvorate, we’re reshaping the medical aesthetics experience by creating a tech-enabled, virtual clinic chain that connects consumers with fully vetted healthcare professionals (HCPs). Our platform solves the industry’s largest barrier—trust—by ensuring safe, ethical treatments through verified HCPs, transparent pricing, and superior post-treatment support. Operating in the UK aesthetics market, which we estimate to be worth in excess of £700m annually, but which could grow to £1.9bn if those considering treatment start, based on our internal market expertise and experience. Rejuvorate is targeting both the considerers who hesitate due to trust, safety, and cost concerns—an estimated 1.6m consumers in the UK—and those who have exited the market prematurely due to poor outcomes or experiences. With revenue generated via our highly scalable model launching in the UK soon, we see future growth opportunities globally, through expanding our treatment portfolio and introducing product or service subscriptions. Investment-ready: Rejuvorate has received SEIS/EIS advanced assurance, offering investors access to tax-efficient investment opportunities.

View contact profiles from Rejuvorate